Skip to main content
Home
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Subscribe
Home
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Breast Cancer
FDA Updates
,
Breast Cancer
Kisqali (Ribociclib): Second CDK4/CDK6 Inhibitor Approved for Postmenopausal Women with HR-Positive, HER2-Negative Advanced Breast Cancer
Lisa A. Raedler, PhD, RPh, Medical Writer
Read More
FDA Updates
,
Breast Cancer
Verzenio (Abemaciclib) a New CDK4/CDK6 Inhibitor Approved for HR-Positive, HER2-Negative Advanced or Metastatic Breast Cancer
Loretta Fala, Medical Writer
Read More
Breast Cancer
Breaking News: Sellas Announces Promising Data on NeuVax in Combination with Herceptin in HER2 1+/2+ Breast Cancer
Read More
Breast Cancer
Immunotherapy Continues to Gain Momentum in Breast Cancer
Read More
Breast Cancer
Arm Morbidity Higher with Extensive Lymph Node Surgery in Younger Patients with Breast Cancer
Read More
Breast Cancer
Dose-Intense Chemotherapy Shown to Improve Outcomes in Patients with Breast Cancer
Read More
Breast Cancer
Review of Ribociclib for Advanced Hormone Receptor–Positive Breast Cancer
Lowell L. Hart, MD
Read More
Breast Cancer
Bevacizumab in Metastatic Breast Cancer: Ready for Prime Time?
Katherine Mandock, PharmD, BCPS
,
Scott Soefje, PharmD, MBA, BCOP, FCCP, FHOPA
,
Val R. Adams, PharmD, FCCP, BCOP
Read More
Breast Cancer
Estrogen Alone Poses No Increased Breast Cancer Risk
Caroline Helwick
Read More
Breast Cancer
Patients Discovering Breast CancerTrials.org
Caroline Helwick
Read More
7
8
9
10
11
Page 10 of 11
Results 91 - 100 of 101